NDC 53225-1111-01 - BONDLIDO

This NDC is not currently matched to an FDA NDC product listing in FDA.report, but it is a valid NDC-form code. FDA.report is showing the available DailyMed label context for the product root.

Product NDC
53225-1111
Requested NDC
53225-1111-01
Package NDCs from labels
53225-1111-1, 53225-1111-3, 53225-1111-01
Manufacturer
Terrain Pharmaceuticals, Inc.
Effective date
2026-09-30
Current FDA listing
Not matched in FDA.report NDC product tables

DailyMed Labels#

Label, Manufacturer, Effective date table
LabelManufacturerEffective dateType
BONDLIDO - Terrain Pharmaceuticals, Inc.Terrain Pharmaceuticals, Inc.2026-09-30HUMAN PRESCRIPTION DRUG LABEL

openFDA label cross-check#

OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.

Matched openFDA labels page 22 of 50 · 996 matching rows.

Brand, Generic, Manufacturer table
BrandGenericManufacturerSPL set IDEffective dateAvailable safety fieldsJoin
Lidocaine Pain Relief Gel PatchLIDOCAINE PAIN RELIEFDynarex960e4240-cd09-2560-e053-2a95a90a7bcf2026-01-28WarningsExact identifier
unii: 98PI200987
LidocaineLIDOCAINEFougera Pharmaceuticals, LLC88ca9cba-0c4a-482f-b502-ceefdb1bfbcd2026-01-28Warnings, Adverse reactionsExact identifier
unii: 98PI200987
LidocanLIDOCAINE 5%PURETEK CORPORATIONfd8e4856-3785-4850-e053-6294a90a95b62026-01-27Warnings, Adverse reactionsExact identifier
unii: 98PI200987
Lidocaine Pain ReliefLIDOCAINETrifecta Pharmaceuticals USA, LLC.493c09d0-16d7-7413-e063-6394a90aa0522026-01-26WarningsExact identifier
unii: 98PI200987
CVS 9083 Maximum Strength Lidocaine 4 Pain Relief Patch 1ct LargeLIDOCAINECVS PHARMACY, INC4914965f-1164-e20e-e063-6294a90ac2212026-01-23WarningsExact identifier
unii: 98PI200987
Black Cobra Tattoo NumbingSpray 4% LidocaineLIDOCAINEFoshan Sugar Max Cosmetics CO.,Ltd3605fcbf-63c8-87b5-e063-6294a90a9c3e2026-01-19WarningsExact identifier
unii: 98PI200987
Black Cobra Tattoo Numbing Cream 4% LidocaineLIDOCAINEFoshan Sugar Max Cosmetics CO.,Ltd3605961a-d596-9c4a-e063-6394a90a99dc2026-01-19WarningsExact identifier
unii: 98PI200987
DYNAMO DELAY SAMPLE BOTTLELIDOCAINEMomentum Management LLC05370186-1b82-4d0f-9382-b153252c02212026-01-19WarningsExact identifier
unii: 98PI200987
Aspercreme with LidocaineLIDOCAINEChattem, Inc.7ad8efa9-7031-4cd0-be1d-6dee63091fd12026-01-19WarningsExact identifier
unii: 98PI200987
TOPCARE PAIN RELIEF PATCHESLIDOCAINETOPCO ASSOCIATES, LLCfa2f7768-e779-4409-aad3-6c33ce2e6b362026-01-18WarningsExact identifier
unii: 98PI200987
Aspercreme with Lidocaine XLLIDOCAINEChattem, Inc.b0859b10-539e-4905-ab52-af78b778d6a42026-01-15WarningsExact identifier
unii: 98PI200987
Pain Relieving PatchLIDOCAINEFlexiGo Inc.4868af2a-c4be-9c68-e063-6394a90a565b2026-01-15WarningsExact identifier
unii: 98PI200987
Hemorrhoid and FissureGLYCERIN 6%,LIDOCAINE 4%,ECTOIN 0.12%FlexiGo Inc48697377-61c0-1b0a-e063-6294a90a32932026-01-15WarningsExact identifier
unii: 98PI200987
Careland Lidocaine 4 Pain Relieving Gel-PatchesLIDOCAINEPlanet (Anhui) Pharmaceutical Co., Ltd.a6ca8382-7ce5-4df9-912e-8a0ac04231162026-01-15WarningsExact identifier
unii: 98PI200987
Icy Hot Lidocaine DryLIDOCAINE, MENTHOLChattem, Inc.d500a74e-ab93-4919-8665-a89e9d4cad282026-01-15WarningsExact identifier
unii: 98PI200987
LIDOCORE (single unit patch)LIDOCAINE 4%Ion Pharma, LLC161f5745-fec1-4ca3-be42-512f6d3e7fee2026-01-14WarningsExact identifier
unii: 98PI200987
LIDOCORELIDOCAINE 4%Ion Pharma, LLC12dec398-1082-45ad-a517-8f12873b19092026-01-14WarningsExact identifier
unii: 98PI200987
LidocaineLIDOCAINE 4%AvKARE70aace2f-47b4-e961-e053-2991aa0a63672026-01-14WarningsExact identifier
unii: 98PI200987
LidocaineLIDOCAINEAvKARE0a4cc4f8-9c5d-d03f-e063-6394a90a1b2e2026-01-14Warnings, Adverse reactionsExact identifier
unii: 98PI200987
Icy Hot with Lidocaine No-MessMENTHOL AND LIDOCAINEChattem, Inc.a2803c07-bf39-4028-9262-5082da25b46e2026-01-14WarningsExact identifier
unii: 98PI200987

Reported adverse events (FAERS/openFDA)#

Adverse event summaries are temporarily unavailable. Other product information remains available.